Please also visit GetIPT.com

Site outline:
Choosing IPT
Find a Doctor
IPT Training
About IPT
Other Diseases
Doctors Listing
Patient Stories
Patients Home
Articles & pubs
Site Index
About Us
Tell a Friend

This level:  
CNS Injury
Expedition & Space
Sports & Rehab





Up ] Bioterrorism ] Infections ] Alzheimer's ] CNS Injury ] [ Eyes ] Ears ] Poisoning ] Anti-Aging ] Appendicitis ] Dental ] Transplants ] DevelopngWorld ] Emergency ] Battlefield ] Expedition & Space ] Sports & Rehab ]

Future Possibilities and Speculations about IPT
by Chris Duffield

        Ophthalmology researchers ought to look into IPT.  Here are some clues that IPT could enable better and faster treatment of eye diseases.


  1. IPT has been shown, time after time, to improve transport of medications across the cell membranes and into otherwise impermeable tissues throughout the body.   I suggest that it is very likely that IPT will assist transport of medications to be delivered, and toxins to be eliminated, across the blood-aqueous barrier, the blood-vitreous barrier, and the blood-retinal barrier.  This would be an entirely new strategy for getting drugs into the eyes.  Eye specialists may develop empirical methods that intentionally use these transport opportunities.  

  2. The US insulin study group of the 1930s reported improvements in vision after injection of small amounts of slow insulin into the body.  Their theory and observation was that ectodermal tissue would be most affected by insulin, and the optic nerve, retina, and lens are of ectodermal origin.  Two quotes from the review paper:  "Still another [doctor], using insulin for a periodontal case, found simultaneous improvement in the patient’s long standing double vision."    "Dramatic results have been noted in people with certain eye problems.   Retrobulbar neuritis has responded back to normal with three injections over a period of two weeks.  'Leaky' retinas have stopped leaking after two to three injections, but treatment is usually continued for three weeks. Injections for eye problems (ectodermally related) are given where a dentist gives an anesthetic for an upper first or second bicuspid.  Injection is shallow."     It could be that IPT will be even more effective, especially when combined with appropriate medications.  

  3. This mention of the stopping of retinal leaking could be very significant.  Age-related macular degeneration (AMD) is the leading cause of vision loss with aging.   "Wet" macular degeneration, the most serious kind, is responsible for 90 percent of the severe loss of vision, and with some 200,000 new cases per year in the US alone.  Wet AMD involves neovascularization (new blood vessels) in the retina, which then begin to leak and cause irreversible damage.  Laser photocoagulation can seal the leaks, but at the cost of damaging more retinal area.  Some other methods are being tried, including antiangiogenic drugs, sub-macular surgery, and laser photodynamic therapy.  All of these methods are expensive, requiring advanced technologies out of the reach to most human beings who need help.  Wouldn't it be wonderful if a few injections of slow insulin stopped retinal leaking as a few doctors claimed in the 1930s?  Wouldn't it be wonderful if a simple, inexpensive IPT treatment could be developed for macular degeneration?   

  4. One of Dr. Paquette's patients:  "This journalist treated for circulatory troubles who, the day after her treatment, while trying to read her newspaper, exclaimed aggressively: "How it is that I cannot read with my glasses?"   I told her to remove them. Surprised, she realized that she could read without her glasses for the first time in 5 years."  Perhaps IPT will be found to be able to rejuvenate the lens of the eye in people past middle age, so that its range of focus increases.  Can IPT reduce or eliminate the need for reading glasses?

  5. Another of Dr. Paquette's patients, a young actress with viral hepatitis.  "In a few days, after the ICT treatment, her blood chemistry becomes normal again, to her great surprise her vision and hearing improve."

  6. Dr. Paquette wrote that when he noticed yellowish corneas, he immediately suspected liver toxicity and biliary dyskinesia.  It could be that detoxification of the liver and the body with IPT could reduce or reverse this symptom.

    [IPTQ Webhost Update 7/11/03:  A biliary dyskinesia patient has suggested that Dr. Paquette's ideas about this condition are incorrect or out of date.  She provided these links for more recent information: 1, 2, and 3.  It appears that Dr. Paquette was using this term to refer to a wider range of problems, "Bad elimination of bile", which IPT might be able to address.]

  7. There is some evidence that diabetes-related loss of vision may be treatable with IPT.  The Drs. Perez Garcia report such a case in the 1992 patent.  "At the end of the first IPT treatment the patient reported improvement in his eyesight."

  8. I believe that somewhere in my archives is at least one case study of rapid and successful IPT treatment of glaucoma by Dr. Perez Garcia y Bellon 2.  

  9. Retinitis pigmentosa is a group of hereditary disorders whose common feature is a gradual deterioration of the light sensitive cells of the retina.  IPT could be an efficient way to deliver drugs and nutrients across the blood-retinal barrier, which could open the way to innovative treatments to slow or halt the processes of chronic degeneration.  


This level: Up ] Bioterrorism ] Infections ] Alzheimer's ] CNS Injury ] [ Eyes ] Ears ] Poisoning ] Anti-Aging ] Appendicitis ] Dental ] Transplants ] DevelopngWorld ] Emergency ] Battlefield ] Expedition & Space ] Sports & Rehab ] 

Site index: Home ] Choosing IPT ] Find a Doctor ] IPT Training ] . ] About IPT ] Cancer ] Other Diseases ] Doctors Listing ] First Doctors ] Patient Stories ] Patients Home ] Articles & pubs ] Books ] Action ! ] . ] News ] Search ] Site Index ] . ] About Us ] Links ] Tell A Friend ]

Tell a friend about IPTQ.com
Entire IPTQ website Copyright 1999-2002 by Chris Duffield, Ph.D.  All rights reserved.
IPTQ, IPTQ.org, IPTQ.com, IPTQ.net, The second discovery of insulin, and IPTQ lifering and lifeboat logos are trademarks. 
Please read the IPTQ.com disclaimer.   
This page was last updated on  March 19, 2008.
Website technical corrections and suggestions -- email to IPTQ Webhost.
Please also visit GetIPT.com
website visitors since August 2002
Click on box for detailed statistics)

Chris Duffield, webhost